Xiaoping Gu - Concepedia

Author

Xiaoping Gu

Indiana University – Purdue University Indianapolis

Also Known As

X Gu, X. X. Gu, XiaoPing Gu, Xiaoping Gu

Publications

260

Citations

H-Index

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine Indiana University Health University of Virginia The University of Texas MD Anderson Cancer Center

About

Xiaoping Gu is an author at Indiana University – Purdue University Indianapolis specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	129
2	Cell Biology	2	2	92
3	Biochemistry	1	1	37
4	Microbiology	1	1	37
5	Pathology	1	1	79

Xiaoping Gu

Publications

242

Citations

H-Index

Page 1

	Year	Citations
Splicing factor <i> <scp>ESRP</scp> 1 </i> controls <scp>ER</scp> ‐positive breast cancer by altering metabolic pathways Yesim Gökmen‐Polar, Yaseswini Neelamraju, Chirayu Goswami, EMBO Reports Transcriptional RegulationMetabolic PathwaysMedicineCancer Cell BiologyPathology	2019	79
<i>Haemophilus ducreyi</i> SapA Contributes to Cathelicidin Resistance and Virulence in Humans Kristy L. B. Mount, Carisa A. Townsend, Sherri D. Rinker, Infection and Immunity	2010	42
Deletion of <i>mtrC</i> in Haemophilus ducreyi Increases Sensitivity to Human Antimicrobial Peptides and Activates the CpxRA Regulon Sherri D. Rinker, Michael P. Trombley, Xiaoping Gu, Infection and Immunity Microbial PathogensBacteriologyCpxra RegulonAntibiotic ResistanceBacterial Pathogens	2011	37
Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer Yesim Gökmen‐Polar, Yaseswini Neelamraju, Chirayu Goswami, Modern Pathology	2014	35
The rrs (16S)-rrl (23S) ribosomal intergenic spacer region as a target for the detection of Haemophilus ducreyi by a heminested-PCR assay Xiaoping Gu, R. Rossau, Geert Jannes, Microbiology	1998	24
Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer Yesim Gökmen‐Polar, Jason D. True, Edyta Vieth, PLoS ONE Tumor Suppressor Dlc1Breast OncologyMedicineCancer GenomicsLow Expression	2018	13
Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways Yesim Gökmen‐Polar, Yaseswini Neelamraju, Chirayu Goswami,	2019	12

Page 1